Latest Breaking News On - ஆராய்ச்சி பயன்பாடு மட்டும் - Page 5 : comparemela.com

Applied DNA Sciences : Launches Linea™ COVID-19 Selective Genomic Surveillance™ Mutation Panel to Boost SARS-CoV-2 Variant Detection and Tracking Nationally

Message : Required fields Positioned as Screening Platform for Efficient Use of Private, State and Federal Next Generation Sequencing (NGS) Resources to Enhance Variant Testing Newly Developed PCR Panel Detects Specific Mutations to Focus Limited NGS Capacity on Most Impactful Variants of SARS-CoV-2 Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the launch of its Linea™ COVID-19 Selective Genomic Surveillance™ (SGS) Mutation Panel (the “SGS Panel”) to enhance the utility of limited Next Generation Sequencing (NGS) resources in the United States to track better the SARS-CoV-2 Variants of Concern (VOCs) at local, state, and federal levels. The SGS Panel uses a matrix of proprietary quantitative polymerase chain reaction (qPCR) assays that target salient mutations that characterize relevant identified VOCs to narrow the selection of positive samples worth subjecting to NGS

United statesJames haywardMutation panelSciences incResearch use onlyClinical laboratory improvement amendmentsCompany lineaClinical laboratory newsPolymerase chain reactionGenomic surveillanceNext generation sequencingGenetic engineeringBiotechnology newsAssay kitRussell microcapApplied dna sciences

LexaGene Holdings Inc advances its pathogen-detection technology in battle against coronavirus

LexaGene Holdings Inc advances its pathogen-detection technology in battle against coronavirus
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

South africaUnited kingdomUnited statesSouth africanLexagene miqlabDaryl rebeckStephen mastrocolaJack reganResearch useErnst youngDrug administrationUs department of homeland securityLexagene holdings incGene holdings incHomeland securityEmergency use authorization

(ADPT), Laboratory Corporation of America Holdings (NYSE:LH) - Adaptive Bio Launches T-Cell Based COVID-19 Tests

Adaptive Biotechnologies Corp (NASDAQ: ADPT) launched a clinical T-cell-based test kit to confirm recent or prior COVID-19 .

United statesResearch useLaboratory corpAmerica holdingsAdaptive biotechnologies corpLab corpEmergency useResearch use onlyஒன்றுபட்டது மாநிலங்களில்ஆராய்ச்சி பயன்பாடுஆய்வகம் கார்ப்அமெரிக்கா ஹோல்டிங்ஸ்மாற்றி அமைக்கத்தக்க உயிரி தொழில்நுட்பங்கள் கார்ப்அவசரம் பயன்பாடுஆராய்ச்சி பயன்பாடு மட்டும்

Menarini Silicon Biosystems announces launch of CellMag product line offering affordable Gold Standard Circulating Tumor Cells capture

(2) CELLMAG - a cost effective, manual and simple approach for the enrichment and staining of extremely rare cells from blood BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Feb. 16, 2021 /PRNewswire/ Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the launch of its innovative CellMag product line for the manual enrichment and staining of rare circulating tumor cells (CTCs). This new product line, composed of the CellMag CTC Epithelial Cell kit, a magnetic tool and consumables, will allow all liquid biopsy and CTCs Laboratories to have access to a manual system using the same ferrofluid technology offered by the Gold Standard CELLSEARCH system.

Catherine alix panabiKostenloser wertpapierhandelFabio piazzalungaLinda pavyLaboratory of rare human circulating cellsMenarini groupUniversity medical centerResearch use onlySilicon biosystemsGold standardAssociate professorRare human circulating cellsMenarini silicon biosystemsHuntingdon valleyDrug delivஆய்வகம் ஆஃப் ரேர் மனிதன் சுற்றும் செல்கள்

Menarini Silicon Biosystems announces launch of CellMag™ product line offering affordable Gold Standard Circulating Tumor Cells capture

Menarini Silicon Biosystems announces launch of CellMag™ product line offering affordable Gold Standard Circulating Tumor Cells capture News provided by Share this article Share this article CELLMAG – a cost effective, manual and simple approach for the enrichment and staining of extremely rare cells from blood BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Feb. 16, 2021 /PRNewswire/ Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the launch of its innovative CellMag product line for the manual enrichment and staining of rare circulating tumor cells (CTCs). This new product line, composed of the CellMag CTC Epithelial Cell kit, a magnetic tool and consumables, will allow all liquid biopsy and CTCs Laboratories to have access to a manual system using the same ferrofluid technology offered by the Gold Standard CELLSEARCH system.

Catherine alix panabiFabio piazzalungaLinda pavyLaboratory of rare human circulating cellsMenarini groupResearch use onlyUniversity medical centerSilicon biosystemsGold standardAssociate professorRare human circulating cellsMenarini silicon biosystemsHuntingdon valleyDrug delivஆய்வகம் ஆஃப் ரேர் மனிதன் சுற்றும் செல்கள்ஆராய்ச்சி பயன்பாடு மட்டும்